Since many inflammatory mediators are activated in cancer cachexia, and the miR199a/Cav1 axis was previously described in several chronic inflammatory lung diseases as an important regulatory pathway [84], this axis should also be considered for further investigations in muscle wasting in cancer cachexia. The gene discussed is CAV1; the disease is cancer.